[EN] SMARCA DEGRADERS AND USES THEREOF<br/>[FR] AGENTS DE DÉGRADATION DE SMARCA ET LEURS UTILISATIONS
申请人:KYMERA THERAPEUTICS INC
公开号:WO2020251971A1
公开(公告)日:2020-12-17
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same for the modulation of one or more SWI/SNF-related matrix associated actin dependent regulator of chromatin subfamily A (SMARCA) and/or polybromo-1 (PB-1) protein via ubiqitination and/or degradation by compounds. The compounds are bifunctional molecules that link a cereblon-binding moiety to a ligand that binds SMARCA and/or PB1 proteins.
本发明提供化合物、其药学上可接受的组合物,以及利用这些化合物调控一个或多个SWI/SNF相关基质相关肌动蛋白依赖的染色质亚家族A(SMARCA)和/或聚溴-1(PB-1)蛋白通过化合物的泛素化和/或降解的方法。这些化合物是双功能分子,将结合到cereblon的部分与结合到SMARCA和/或PB1蛋白的配体连接在一起。